Resorbable Nerve Conduits Companies and Market Forecast
The global resorbable nerve conduits market size was estimated at US$ 2.31 billion in 2023 and is projected to grow to US$ 5.28 billion by 2034, rising at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2034.
Top Companies in Resorbable Nerve Conduits:
- AxoGen
- Integra Lifesciences
- Boston Scientific Corp.
- Medtronic
- Baxter
- Regenity Bioscience
- NEUROMetrix
- Toyobo
- Checkpoint Surgical
- Orthomed
- SIA
- Alafair
- Abbott
- Synapse
- KeriMedical
- Nevro
- Ortho Cell
- Epineuron
Latest Announcements by Industry Leaders
- In June 2024, the CEO and President of Axogen, Karen Zaderej claimed that product innovation is integral to the mission at Axogen. She states, “With the launch of Avive+ Soft Tissue Matrix, the company is enhancing its comprehensive solutions for nerve protection and addressing a significant need for patients with compression to non-transected nerve injuries.”
- In September 2024, Sergio Aguirre, CEO and co-founder of Epineuron expressed his proud the success of the company by stating “the delightfulness to see the translation of regenerative electrical stimulation into a product that has the possibility to fit the broadest set of surgical applications in peripheral nerve.”
Recent Development
- In June 2024, Axogen, a leading company focused on peripheral nerve regeneration and repair, launched the Avive+ Soft Tissue matrix. This is a resorbable and multi-layer amniotic membrane allograft which offers temporary protection and tissue separation during the healing of peripheral nerve.
- In June 2024, NurExone Biologic Inc. a pioneering biopharmaceutical company, announced their pre-clinical study to explore the potential of NurExone’s Exosome-based therapies in regenerating damaged optic nerves.
If you have any questions, please feel free to contact us at
